Lilly Cymbalta Detailing To Increase Double Digits In 2006
This article was originally published in The Pink Sheet Daily
Executive Summary
The company hopes its neuroscience sales force reorganization and Cymbalta physician marketing program will drive antidepressant sales.
You may also be interested in...
Cymbalta Buoyed By Branded Ad Campaign
Sales of Lilly’s antidepressant more than doubled in the first quarter.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.